Oscar Health Inc. (NYSE: OSCR) on Tuesday reported fourth-quarter revenue of approximately $2.81 billion, compared to $2.39 billion a year ago, missing the consensus estimate of $3.12 billion.
Total revenue was approximately $11.7 billion for fiscal 2025 compared to $9.2 billion a year ago, driven by higher membership, partially offset by an increase in the net risk adjustment transfer accrual.
The medical loss ratio was 95.4% for the quarter compared to 88.1% a year ago. The increase was primarily driven by higher average market morbidity that resulted in an increase in the net risk adjustment transfer accrual, as well as higher utilization that was not fully offset by risk adjustment.
The health care technology company reported a loss of $1.24 per share, missing the consensus estimate of 89 cents.
The SG&A expense ratio was 18.2% compared to 19.5%. The decrease was primarily due to greater fixed cost leverage, lower exchange fee rates, and disciplined …